The Mayo Clinic CohortThe Mayo Clinic
About the Study:
In the mid 1970’s, all women and men who were and were not prenatally exposed to DES and were born at the Mayo Clinic between 1940 and 1960 were identified through review of medical records. All of the women were invited to participate in the National Cooperative Diethylstilbestrol Adenosis (DESAD) project. These women continue to be followed for numerous health outcomes within the Daughters’ cohort of the DES Follow-Up Project.
In the late 1970’s, the men who had been identified were asked to participate in a study of DES exposure and genitourinary anomalies. These men continue to be followed in the Sons’ cohort of the DES Follow-up Project.
About the Principal Investigators:
Dr. Andrea L. Cheville is the Principal Investigator. She is a Health Services Researcher who focuses on the development of novel supportive care delivery strategies to improve outcomes and contain costs among patients with cancer. Additionally, Dr. Cheville is a board certified clinician in Physical Medicine and Rehabilitation, Pain Management, and Hospice Medicine and Palliative Care who treats wide-ranging functional problems and symptoms related to cancer.